Detalhe da pesquisa
1.
N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.
Cell Mol Life Sci
; 81(1): 73, 2024 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38308713
2.
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Nucleic Acids Res
; 49(5): 2859-2877, 2021 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33577677
3.
PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.
Mol Oncol
; 18(3): 580-605, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38060346
4.
USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression.
Mol Oncol
; 18(1): 170-189, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37867415
5.
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC.
Adv Sci (Weinh)
; 11(15): e2305541, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38351659
6.
Regulation of SUMOylation on RNA metabolism in cancers.
Front Mol Biosci
; 10: 1137215, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36911524
7.
Glucose-mediated N-glycosylation of RPTPα affects its subcellular localization and Src activation.
Oncogene
; 42(14): 1058-1071, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36765146
8.
Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression.
Oncogene
; 41(44): 4877-4892, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36192478
9.
Hypoxia regulates overall mRNA homeostasis by inducing Met1-linked linear ubiquitination of AGO2 in cancer cells.
Nat Commun
; 12(1): 5416, 2021 09 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34518544